PDS Biotechnology Corp
PDSB· Nasdaq
PDSBPDS Biotechnology Corp
Filed Aug 1, 2019 · 10-Q · 32 days after period end · 0001140361-19-013922
| Metric | Q2 2019 | Q2 2018 | Q2 2017 | Q2 2016 |
|---|---|---|---|---|
| Net Income | -$3.89M | -$567.83K | -$13.50M | -$9.38M |
| EPS Diluted | -$0.75 | -$0.17 | — | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
PDS Biotechnology Corp · CIK 1472091 · Engraved from SEC EDGAR
ended Jun 30, 2019 · filed Aug 1, 2019 · 32 d after period end
